Condition: Coronary Artery Disease · Microvascular Dysfunction · Sponsor: Johannes Gutenberg University Mainz
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
This description comes directly from the study's public registry record.
Tommaso Gori, PhD, Dott medicina e Chirurgia · +49 6131 172829 · tommaso.gori@unimedizin-mainz.de
Always discuss trial participation with your own doctor first.
| University Medical Center Mainz - 2 Medizinische Klinik | Mainz, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02180178